6 Colo. Code Regs. § 1007-1-7G
Except as provided in Appendix 7P, the licensee shall require an authorized user for the oral administration of sodium iodide requiring a written directive in quantities less than or equal to 1.22 Gigabecquerels (33 millicuries), to be a physician who:
7G1 Is certified by a medical specialty board whose certification process includes all of the requirements in 7G3.1 and 7G3.2 of this Appendix and whose certification process has been recognized by the NRC or an Agreement State. The names of board certifications that have been recognized by the NRC or an Agreement State are posted on the NRC's Medical Uses Licensee Toolkit web page;
or
7G2 Is an authorized user under Appendix 7F for uses listed in 7F2.1(2)(f)(i) or 7F2.1(2)(f)(ii), Appendix 7H, or equivalent NRC or Agreement State requirements;
or
7G3
7G3.1 Has successfully completed 80 hours of classroom and laboratory training, applicable to the medical use of sodium iodide I-131 for procedures requiring a written directive. The training must include:
(1) Radiation physics and instrumentation;
(2) Radiation protection;
(3) Mathematics pertaining to the use and measurement of radioactivity;
(4) Chemistry of radioactive material for medical use; and
(5) Radiation biology;
and
7G3.2 Has work experience, under the supervision of an authorized user who meets the requirements in Appendix 7P, Appendix 7F, Appendix 7G, Appendix 7H or equivalent Agreement State or NRC requirements. A supervising authorized user, who meets the requirements in 7F2, must also have experience in administering dosages as specified in 7F2.1(2)(f)(i) or 7F2.1(2)(f)(ii). The work experience must involve:
(1) Ordering, receiving, and unpacking radioactive materials safely and performing the related radiation surveys;
(2) Performing quality control procedures on instruments used to determine the activity of dosages and performing checks for proper operation of survey meters;
(3) Calculating, measuring, and safely preparing patient or human research subject dosages;
(4) Using administrative controls to prevent a medical event involving the use of radioactive material;
(5) Using procedures to contain spilled radioactive material safely and using proper decontamination procedures;
and
(6) Administering dosages to patients or human research subjects that includes at least 3 cases involving the oral administration of less than or equal to 1.22 gigabecquerels (33 millicuries) of sodium iodide I-131;
and
7G3.3 Has obtained written attestation that the individual has satisfactorily completed the requirements in 7G3.1 and 7G3.2, and is able to independently fulfill the radiation safety-related duties as an authorized user for oral administration of less than or equal to 1.22 gigabecquerels (33 millicuries) of sodium iodide I-131 for medical uses authorized under 7.36. The attestation must be obtained from either:
(1) A preceptor authorized user who meets the requirements in Appendix 7P, Appendix 7F, Appendix 7G, Appendix 7H, or equivalent NRC or Agreement State requirements and has experience administering dosages as specified in 7F2.1(2)(f)(i) or 7F2.1(2)(f)(ii);
or
(2) A residency program director who affirms in writing that the attestation represents the consensus of the residency program faculty where at least one faculty member is an authorized user who meets the requirements in Appendix 7P, Appendix 7F, Appendix 7G, Appendix 7H, or equivalent NRC or Agreement State requirements, has experience in administering dosages as specified in 7F2.1(2)(f)(i) or 7F2.1(2)(f)(ii), and concurs with the attestation provided by the residency program director. The residency training program must be approved by the Residency Review Committee of the Accreditation Council for Graduate Medical Education or the Royal College of Physicians and Surgeons of Canada or the Council on Postdoctoral Training of the American Osteopathic Association and must include training and experience specified in 7G3.1 and 7G3.2.
6 CCR 1007-1-7G